We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




David Pall, Founder of Pall Corporation, Dies at 90.

By Labmedica staff writers
Posted on 07 Oct 2004
Dr. More...
David B. Pall, a chemist who founded the Pall Corporation in 1946 to commercialize his invention of a novel metallic filtration material, died on September 21, 2004, at his home in Roslyn Estates (NY, USA). He was 90.

David Boris Pall was born in Thunder Bay, Ontario (Canada) in April 1914, the son of Russian immigrants. He received his Ph.D. in physical chemistry from McGill University (Montreal) in 1939. After that, he moved to New York (NY, USA), where he worked as a research chemist on the Manhattan Project, a secret program resulting in the development of the atomic bomb.

In 1944, Dr. Pall began working in his garage on a metallic filter that would be able to handle heavy pressure, high temperatures, and corrosive materials. He invented many different kinds of filters and received 181 U.S. patents on his designs. Some designs were for filters used aboard airplanes or on helicopter engines. After his first wife, Josephine, died of plastic anemia, he invented filters for purifying blood used in transfusions that have made the procedure much safer by protecting transfused patients from viruses and other harmful pathogens.

Dr. Pall established a company called the Micro Metallic Corp. in East Hills, NY (USA) to distribute his new designs. The name was later changed to the Pall Corporation, which grew into a global company and a world leader in filtration under his tenure. In 1990, Dr. Pall was awarded the U.S. National Medal of Technology, the nation's highest honor in technology. Dr. Pall retired as chairman of Pall Corporation in 1992.

New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Gel Cards
DG Gel Cards
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.